Inside the unconventional FDA panel that could reshape the peptide industry
An unconventional FDA panel is assessing the safety and efficacy of previously-banned peptides. It could open up a multibillion-dollar market.
Peptides are under scrutiny in an FDA meeting running July 23-24Olena Malik/Getty ImagesAn unconventional FDA panel is reviewing peptide safety, focusing on banned therapeutic peptides.The FDA raised concerns over peptide safety, citing immune reactions and a lack of evidence of efficacy.Better access to peptides could open up a multibillion-dollar market for telehealth companies.
Nearly 2 years after Robert F. Kennedy Jr. vowed to end the FDA's "war" on peptides, he has convened an unusual FDA advisory committee.
A panel is meeting this week to weigh the future of several popular peptides — including trendy compounds prized for injury recovery, fat loss, and sleep that the FDA has banned.Unlike a typical FDA panel, several members make their living prescribing, researching, or selling peptide therapies, raising questions about how the debate will unfold.The compounds under review aren't GLP-1 drugs or insulin — both FDA-approved peptides.
These are lesser-studied injections that have gained traction in fitness and wellness circles.Under Kennedy's leadership, this team of doctors, peptide sellers, and pharmaceutical experts is evaluating 7 compounds that the FDA recently barred pharmacies from compounding in the US. On the first day of the meeting, July 23, the panel voted to approve the ever-popular "wolverine" shot, BPC-157, marketed for speedy recovery and wound healing.
Others being discussed during the two-day meeting include TB-500 (touted for wound healing) and epitalon (ostensibly a hack for insomnia).Here's a breakdown of the big issues and power players you need to know to wrap your head around the fiery debate.What is a peptide?
Peptides are an incredibly broad category of substances.At the most basic level, they're signaling molecules that aren't long enough to be considered proteins. Our bodies produce thousands of peptides every day.
Insulin, GLP-1 drugs, and the growth hormone tesamorelin are all peptides that are already FDA-approved to treat certain con
Đọc thêm từ Kinh doanh
Top investment bank: Starmer and Reeves left UK ‘no better off than they found it’
Keir Starmer and Rachel Reeves failed to leave the economy in a better position than they found it, according to top investment bank, which said the administration’s fixation on “luxury beliefs” kneecapped its number one mission to revive Britain’s flagging growth. In a research
Science Says 1 Emotion Best Predicts Whether You Will Someday Feel You Lived a Meaningful Life
The key to feeling your life has, and had, meaning? Hope.
Futures are up after yesterday's rout. Oil eased. Intel surged. New tariffs hit at midnight
S&P 500 futures added 0.2% Friday morning after the index posted its worst single-day drop since late June
Are employers hiring for today's labour market or the one they already know?
Applications per role have roughly doubled since 2022, yet business leaders are telling me they can't find the talent they need. Something isn't adding up.